COVID-19 Grants

Last year, in response to the COVID-19 pandemic, the BMA Foundation offered an additional grant worth £65,000 for research into new and ongoing COVID-19 research.

We received a total of 57 applications, ranging from basic to clinical science, and also on COVID-19, from the perspective of public health and therapeutic angles.

Grant winner

The effect of raised cardiovascular risk on COVID-19 incidence and outcomes

By early August 2020, the COVID-19 pandemic had led to more than 19 million cases and over 715,000 deaths worldwide.

Underlying health problems such as heart disease rapidly emerged as a major risk factor for severe illness and death from COVID-19. Cardiac injury is common among patients hospitalised with COVID-19 and increases the risk of poor outcomes.

We already know that other acute respiratory infections such as influenza can trigger heart attacks and strokes among vulnerable patients. While COVID-19 affects the cardiovascular system, it is not clear exactly who is vulnerable to poor outcomes of infection. This evidence is urgently needed to guide targeted prevention and treatment strategies.

In this project, we will investigate the effect of underlying cardiovascular risk profile on severe illness and death from COVID-19. We will use large, powerful anonymised datasets of linked electronic health records from GPs and hospitals as well as national laboratory surveillance data to conduct two studies with complementary designs.

Our work will inform the definition of priority groups for vaccination, when in future a vaccine becomes available, as well as other stratified public health measures and treatments for those at raised cardiovascular risk.

Dr Sarah Blagden’s project “Prognostic markers for COVID-19” was successfully awarded funding from the BMA Foundation in their COVID-19 call.

Her team at the University of Oxford have been exploring the factors that link conditions like diabetes and hypertension to risk of COVID-19.

They hypothesise that people with these conditions have high levels of cellular stress and this predisposes them to heavier viral infection and worse outcomes.

Using blood samples collected from 250 London Healthcare Workers, some of whom later contracted SARS-CoV-2, Sarah will be correlating their medical history and outcomes with levels of circulating cell stress markers.

This work provides a pathophysiological explanation for COVID-19 risk and a quantitative means of measuring risk.

This is important in broadening our understanding of the disease susceptibility as well as defining the factors and interventions that increase or decrease viral risk.

We would like to extend our special thanks to the Rosetrees Trust for their support in match-funding our 2020 COVID-19 response.

Rosetrees is a private charity, supporting medical researchers at different stages of their careers from PhD Plus to junior group leaders through to more senior investigators with an established track record.

Rosetrees are actively funding a number of COVID-19 research projects at some of the UK’s leading institutions, including the BMA Foundation.

Find out more about the Rosetrees Trust here.